These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 12354750

  • 1. Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).
    Campo PA, Das S, Hsiang CH, Bui T, Samuel CE, Straus DS.
    Cell Growth Differ; 2002 Sep; 13(9):409-20. PubMed ID: 12354750
    [Abstract] [Full Text] [Related]

  • 2. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression.
    Kamagata C, Tsuji N, Moriai M, Kobayashi D, Watanabe N.
    Breast Cancer Res Treat; 2007 May; 102(3):263-73. PubMed ID: 17028981
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
    Kondoh K, Tsuji N, Asanuma K, Kobayashi D, Watanabe N.
    Exp Cell Res; 2007 Oct 01; 313(16):3486-96. PubMed ID: 17706193
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells.
    Suk FM, Chen CH, Lin SY, Cheng CJ, Yen SJ, Hung LF, Liu DZ, Liang YC.
    Toxicol Lett; 2009 May 22; 187(1):22-7. PubMed ID: 19429239
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
    Fionda C, Nappi F, Piccoli M, Frati L, Santoni A, Cippitelli M.
    Mol Pharmacol; 2007 Nov 22; 72(5):1246-57. PubMed ID: 17673570
    [Abstract] [Full Text] [Related]

  • 11. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
    Hsiang CH, Straus DS.
    Oncogene; 2002 Mar 28; 21(14):2212-26. PubMed ID: 11948404
    [Abstract] [Full Text] [Related]

  • 12. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells.
    Yokoyama Y, Masaki T, Kiribayashi K, Nakashima A, Kokoroishi K, Ogawa T, Kohno N, Yorioka N.
    Ther Apher Dial; 2010 Feb 28; 14(1):43-51. PubMed ID: 20438519
    [Abstract] [Full Text] [Related]

  • 13. 15-deoxy-Delta12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction.
    Hwang J, Lee HI, Chang YS, Lee SJ, Kim KP, Park SI.
    Biochem Biophys Res Commun; 2007 May 25; 357(1):206-11. PubMed ID: 17418102
    [Abstract] [Full Text] [Related]

  • 14. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells.
    Lee DR, Kwon CH, Park JY, Kim YK, Woo JS.
    Toxicology; 2009 Apr 05; 258(1):17-24. PubMed ID: 19167456
    [Abstract] [Full Text] [Related]

  • 15. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS.
    Kim EH, Na HK, Kim DH, Park SA, Kim HN, Song NY, Surh YJ.
    Carcinogenesis; 2008 Apr 05; 29(4):688-95. PubMed ID: 18192694
    [Abstract] [Full Text] [Related]

  • 16. Cell cycle control during liver development in the rat: evidence indicating a role for cyclin D1 posttranscriptional regulation.
    Awad MM, Gruppuso PA.
    Cell Growth Differ; 2000 Jun 05; 11(6):325-34. PubMed ID: 10910099
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M, Tsuji N, Kobayashi D, Kuribayashi K, Watanabe N.
    Int J Oncol; 2009 May 05; 34(5):1363-72. PubMed ID: 19360348
    [Abstract] [Full Text] [Related]

  • 19. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY, Tseng CC.
    Mol Pharmacol; 2005 Nov 05; 68(5):1203-13. PubMed ID: 16077033
    [Abstract] [Full Text] [Related]

  • 20. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK, Park IS, Park SJ, Yea SS, Choi YH, Oh S, Park SG, Choi IW.
    Life Sci; 2009 Jul 03; 85(1-2):46-53. PubMed ID: 19409914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.